Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | KEGG DRUG | DrugBank | Drug (Description in trials) | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 |
Tocilizumab
💬 (Tocilizumab (USAN/INN), Tocilizumab (genetical recombination) (JAN), Tocilizumab-aazg, Tocilizumab-bavi, Tocilizumab-anoh, TOCILIZUMAB, TOCILIZUMAB-ANOH) | [1] Tocilizumab Tocilizumab (Tocilizumab) | [1] Tocilizumab Tocilizumab | [1] IL6R IL6R 💬
| [11] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [24] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
|